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A recent study utilizing the same database demonstrated that this trend continued, confirming that the trend is real (Bailey et al., 2014) . The latter study reported that the incidence rates of localized, regional and distant colon and rectal cancers had increased for those aged between 20 and 34 years old. Specifically for rectal cancer, this was observed in the slightly older aged group, 35 to 49 years (Bailey et al., 2014) . Such trends are of concerns considering that people in this age range are in the prime of their life and economically most active, contributing to the economy. However, not every developed nation is reporting such a trend. In Japan, although there have been an increase in the incidence of colon and rectal cancers, the increase is attributed to a cohort effect (Minami et al., 2006) , rather than an actual increase in young colon and rectal cancers. We previously reported that the incidence of CRC has been increasing in Brunei Darussalam (Chong et al., 2009 ). However, this study did not assess in detail the age groups when the incidence starts to increase. It is uncertain whether the trends reported from the west will also be observed in the east. Given the differences in the population demographic, especially in the genetic makeup, race/ethnicities along with the differences in social, culture, diet and level of development of a country, it is important to know if there are any differences in the trends of CRC for healthcare planning. Therefore, this study was done to assess the trends among the different age groups for both colon and rectal cancer in Brunei Darussalam, a developing South-East Asian nation.
Materials and Methods
Setting
Brunei Darussalam is a developing nation located on the northeast corner of the Borneo Island in South-East Asia. It has an estimated population of 420,000 (2012 Census) with Malays being the predominant group (68%), followed by the Expatriates (~20%), Chinese (11%) and the Indigenous group (<5%). The health coverage is provided free to the Citizens and permanent residents (Locals) and payment is required for the Expatriate groups. Each district has a government hospital served by multiple strategically located health centers or clinics. The only tertiary referral center (RIPAS Hospital), a 550 bedded hospital covering all subspecialties is located in the Capital (Bandar Seri Begawan) and houses the State Pathology Laboratory (Department of Pathology), which receives and processes all tissue specimens from all the health institutions and centers within the country. A cancer registry which captures all tissue proven malignancies is maintained by the Department of Pathology, RIPAS Hospital from 1984 to the present day.
Patients
Patients with histology proven rectal carcinoma diagnosed between 1991 and 2014 were identified from the Department of Pathology cancers registry (RIPAS Hospital). This cancer registry was started in 1984, however data on age was not available for 1984 and 1985 , and data on the location of large bowel tumors was incomplete in the years before 1991, therefore, these were excluded from analyses.
Data
Data on patient demographic (age, gender and race) and tumor (type of tumor) data was extracted.
Statistical analyses
The age standardized rate (ASR) and Age Specific Incidence Rates (ASIRs) for three time periods (1991-1998, 1999-2006 and 2007-2014 were calculated based on the projected population for Brunei (Population census department, Ministry of Finance) and the world population (WHO data). The population breakdowns of 1994, 2003 and 2010 were used to calculate the ASR and ASIRs. The ASIRs for CRC, rectal cancer and colon cancer were also calculated. The data were coded and entered into the Word Excel program and later entered into the SPSS (version 16.0, Chicago, IL, USA) for analysis.
Results
Over the study period , there were 1,057 cases of CRCs histologically diagnosed. Table 1 shows the demographic of the overall colorectal, rectal and colon cancer cases.
The mean age of diagnosis was 59.3±14.6 years old; for rectum 59.3±14.4 years old and colon 59.3±14.7 years old. For colon cancer, there was no difference in the mean age of diagnosis between the genders, but older among the indigenous and the Chinese.
Over the three time period, the overall ASR increased from 16 per 100,000 (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) 
Rectal cancers
For rectal cancer, the mean age of diagnosis was younger among females (57.8±14.4) compared to males (60.3±14.1, p=0.107) and older among the Chinese (60.4±12.7) compared to the Malays (59.9±15.2), 
Figure 2. The ASIRs for Colorectal Cancer for the Three Time Periods Increasing Incidence of Colorectal Cancer, Starting at a Younger Age for Rectal Cancer in Brunei Darussalam
Indigenous 58.2±13.4) and the Others (52.4±10.6) (ANOVA, p=0.126 for trend). There were more males affected (61.3%; 38.7%) and the predominant tumor type was adenocarcinoma.
The Age Specific Incidence rates (ASIRs) for rectal cancer is shown Table 2 . The incidence started to increase after the 20-24 years age group, becoming more obvious in the 25-29 age groups onwards.
Colon cancers
The summary of the colon cancer is shown in Table  1 . The ASIRs for colon cancer also showed an increase in the incidence, but this is only seen beginning from the 45-49 groups onward up until the 65-69 age groups. Generally, the increase in the ASIRs for colon cancer was not consistent with minor fluctuations between the time periods (Table 3) .
Discussion
The characteristic of our patients with CRC, male predominant, tumor type (adenocarcinoma) and locations (rectum 35.2% and colon 64.8%) are similar to what have been reported regionally and globally (IARC, 2012; Austin et al., 2014; Bailey et al., 2014; Cai et al., 2014 , Elsamany et al., 2914 , Lim, 2014 , Magaji et al., 2014 . However, the mean age of diagnosis in our setting is much younger than those reported in the West. Our mean age of diagnosis is generally comparable to what have been reported in the region (Lim, 2014) . We previously reported that young CRC is common in our setting (Koh et al., 2015) and this is reflected in our finding of a younger mean age of diagnosis. For rectal cancer, the mean age of diagnosis was younger among females compared to males, but not significantly different. Among the racial groups, the Others group was the youngest, but again, this was not significant. For rectal cancer, men were more affected compared to colon cancer. Among the various racial groups, the indigenous group had the highest proportion of rectal cancer. For colon cancer, apart from the gender differences and just slightly more men affected, the demographic are similar to rectal cancers.
Our study showed that the incidence (ASR) of CRC increased between the three time periods 0.45% per year in the first time period (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) to 0.59% per year in the second time period (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) . The ASIRs increased consistently between the three time periods apart from minor fluctuation, whereas the rate in the 40-44 age groups was higher in the 1991-1998 period compared to the 1999-2006 period. The ASIRs for 2007-2014 were consistently higher than the two time periods beginning in the 40-44 year age group. These increase are not unexpected considering that the population has been steadily increasing and growing older. Our findings are similar to that been reported in countries where the incidences of CRC are still increasing (IARC 2012). However, the increase are variable depending on the age groups, bigger and more obvious in the older age groups. What is of concern is the rate of increase between the different time periods 1998 and 1999-2006 , with the exception of the older age group. If the pace of increase continues, the number of CRC cases may suddenly overwhelm the healthcare system. Therefore healthcare planning needs to take in account this possibility. The increase in the ASR and ASIRs varies between countries, and generally correlate with the level of development of the country and this is also reflected in the increasing life expectancy of the particular population. Generally, the more developed a country, the higher the incidence of CRC (IARC, 2012) . In the more developed nations of the West, the rates have actually been decreasing. Increasing trends which are now being seen in the developing nations have already peaked several decades back in the developed nations. Therefore, there trends in the developing nations are lagging behind the trends reported in the West by several decades (IARC, 2014) .
Based on the data from the International Agency for Research on Cancer (IARC 2012), the ASR of CRC reported for men are as follows; Japan (just above 20/100,000 in the late 1970s, peaked and doubled in the early 1990s), Singapore (~25/100,000 in the 1970s to just above 40/100,000 in 2003 with the rate leveling off), China (increasing just above 26/100,000 in 1990 to 35/100,000 in 2006) and Thailand (~7.0/100,000 in 1985 to ~14.0/100,000 in 2006). In Australia and New Zealand, the rates of CRC for men peaked at almost 50/100,000 and ~53/100,000 respectively, and are now declining, following the trends seen in the developed nations of the West. For women, the trends are similar with the exceptions of the overall rates being 20% to 30% lower than their male counterparts. Similarly for women, the rates have stabilized and are actually declining in the developed nations and increasing in the developing nations (IARC, 2012) . These variable rates increase in the incidence between countries in part depends on the baseline rates which is influenced by the genetic and racial make-up of the population, dietary habit and also environmental factors.
Among rectal cancers in our population, the ASIRs increased between the three time periods and the trend started at a younger age group compared to colon cancer. The definite increase and divergence (ASIRs for rectal cancer) started at the 25-29 age groups onward, whereas for colon cancer this was only seen from the 45-49 groups onward. There were some fluctuations in the rates, being slightly higher in the 20-24 years age group for rectal cancer and 30-34 year age group for colon cancer. These perhaps reflected the background fluctuations. Therefore, our findings are similar to those reported in the United States (Bailey et al., 2014) but different to what have been reported in Japan (Minami et al., 2006) . A study in India looking at rectal cancer using several registries have reported conflicting trends with most registries reporting decreasing or no change in the actual mean annual percentage change in men and the converse trend observed in female (Nooyi et al., 2014) . These contrasted their findings based on the estimated changes. A study in Hong Kong, one of the developed nations in the East reported that increasing incidence of CRC in HK was mostly in the older and male population, but not in the younger age group (Yee et al., 2010) . Similar factors as discussed earlier may account for these differences.
Our findings have several implications for both disease and healthcare burden and in the efforts to tackle the increasing problem of CRC. Even though the increase in the ASIRs in our population was small for the younger age groups, reflecting small increases in the absolute number, the trends are worrying. As our population continues to grow or when projected to a larger population, the actual number will be substantial. Similar trends are seen in colon cancers. If these trends are not addressed, there will be an increase in the absolute number of CRC and the number of young cancers will also increase. We have previously demonstrated that young CRC accounted for approximately one in eight of all CRC in our setting (Koh et al., 2015) . It is important to address this issue given that this group of the population is economically active. Furthermore studies have shown that the stages of diseases are usually more advanced compared to the older group. There are studies that have shown that the treatment outcomes are favorable despite the stages of disease (Yeo et al., 2013) . We are currently in the process of planning a national CRC screening program based on fecal occult blood testing and selective screening colonoscopy as the initial test. Based on our findings, the age of screening may need to be lower than the recommended age of 50 years above (Levin et al., 2008; Sung et al., 2015) . However, this will increase the potential workload, straining the already stretched healthcare resource. Therefore, further studies are required to study the trends and also the best strategy to deal with the increasing trends including those in young CRC.
There are several limitations with our study. First the overall number of CRC cases is small and small fluctuations in the number of cases may cause wide fluctuations in the calculated ASR and ASIRs. However, the data captured by our registry is representative for the whole country and therefore, reflected the trends observed in our country. Secondly, the registry only captured histologically proven CRC cases diagnosed in the country and, therefore cases diagnosed outside of the country or without tissue diagnosis (i.e. radiologically) were not included. However, the number of such cases was likely to be very small and the trend of patients going outside of the country for investigations has been decreasing as the healthcare facilities improved. Finally, our study is only a single country study and the trends observed may not be generalized to another population, especially those with different demographic and racial backgrounds. However, despite these limitations, our findings are consistent with what have been reported in other different populations and also showed similarities to the trend reported in the neighboring South-East Asian nations.
In conclusion, our study showed that there was an increase in the incidence of CRC including in the younger age groups. The increase was seen earlier in rectal cancer compared to colon cancer. These mirror the trend reported from the West. Therefore, any health policies including CRC screening program dealing the chronic non-communicable diseases which include CRC need
